GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease

GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease:

Dementia Big
Georgetown University Medical Center today announces the launch of a phase II clinical trial to study the safety of the cancer drug nilotinib and its effects on clinical outcomes and biomarkers in people with Parkinson’s disease.

http://ift.tt/2m1d1MJ